Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 859

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 859
---
 | ​ | ​                         | ​ | ​ | Title:        | ​ | ​ | Chief Executive Officer | ​ |

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

| ​ 
 ​ 
 ​ | Signature          
 /s/ Chris Kim      
 ​                  
 Chris Kim          
 /s/ Scott Dam      
 ​                  
 Scott Dam          | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Title                                                               
 Chief ExecutiveOfficer and Director(principal executive officer)    
 Chief Financial Officer(principal financial and accounting officer) | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Date             
 January 27, 2025 
 January 27, 2025 | ​ 
 ​ 
 ​ |
|:--|:-------------------|:--|:--|:--------------------------------------------------------------------|:--|:--|:-----------------|:--|
| ​ | *                  
 ​                  
 Nicholas Fernandez | ​ | ​ | Director                                                            | ​ | ​ | January 27, 2025 | ​ |
| ​ | *                  
 ​                  
 Eun Sook Lee       | ​ | ​ | Director                                                            | ​ | ​ | January 27, 2025 | ​ |
| ​ | *                  
 ​                  
 Ji Yeon Baek       | ​ | ​ | Director                                                            | ​ | ​ | January 27, 2025 | ​ |

*By: /s/ Chris Kim Chris Kim
Attorney-in-fact

II-5